VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IWWM-11 2022 | A real-world study evaluating combined modality therapy for early-stage Hodgkin lymphoma

Karan Chohan, MD, Mayo Clinic, Rochester, MN, gives an overview of a real-world study which evaluated combined modality therapy in patients with Hodgkin lymphoma (HL), highlighting the improved progression-free survival (PFS) observed in these patients, and further comments on the value of real-world data in this setting. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter